what does tesamorelin / ipamorelin: Frequently asked questions

Discard it immediately. A cloudy or particulate solution indicates protein aggregation. The peptide has denatured and lost biological activity. Proper reconstitution produces a clear, colourless solution. Cloudiness can result from reconstituting too quickly, shaking the vial, or using non-sterile bacteriostatic water. Do not inject cloudy peptide solutions. They will not produce the intended GH response and may contain bacterial contamination.

Reduce your dose by 30–40% and assess tolerance over the next week. Joint pain and edema are signs of excessive GH elevation. Common with supraphysiological exogenous GH but rare with peptide secretagogues at standard doses. If symptoms persist at reduced dosing, discontinue use and consult your prescribing physician. These effects typically resolve within 48–72 hours of cessation.

Continue the protocol. Visceral fat reduction from tesamorelin follows a dose-dependent timeline. Measurable changes typically appear after 8–12 weeks of consistent daily dosing, not four weeks. Growth hormone-mediated lipolysis is a slower process than direct caloric restriction because it relies on hormonal signaling to mobilise stored fat rather than immediate energy deficit. Clinical trial data shows that peak visceral fat reduction occurs at 26 weeks, with linear improvement continuing through month six.

Yellow discoloration indicates oxidative degradation of methionine or tryptophan residues in the peptide chains. The solution has lost bioactivity and should not be used. This happens when peptides are stored in clear vials exposed to light or when the refrigerator temperature fluctuates above 8°C. Moving forward, wrap your vials in aluminum foil or use amber glass vials, and verify that your refrigerator maintains a stable 2–8°C using a separate thermometer (refrigerator door displays are often inaccurate by 3–5°C).

Administer the missed dose as soon as you remember, then resume your regular schedule the following day. Do not double-dose to compensate. The tesamorelin + ipamorelin blend relies on consistent daily pulsatile GH stimulation. Missing one dose will not erase prior progress, but frequent missed doses disrupt the receptor signaling pattern and reduce efficacy. If you miss more than three consecutive doses, expect a temporary return of baseline GH levels and a 7–10 day period to re-establish peak effect.

Do not inject it. Particulate matter indicates either peptide aggregation, bacterial contamination, or foreign debris introduced during reconstitution. Even microscopic particles can trigger immune responses or embolism if injected subcutaneously. Inspect the vial under bright light. If particles are visible, the solution is compromised. This failure mode usually results from using non-sterile technique during reconstitution, storing the peptide at room temperature, or reusing needles to draw doses (which introduces rubber stopper fragments into the solution).

Discard it immediately. Cloudiness at reconstitution indicates one of three failures: contaminated bacteriostatic water, excessive mechanical stress during mixing, or a manufacturing defect in the lyophilized powder. Cloudiness means protein aggregation has already occurred, and aggregated peptides cannot re-fold into their bioactive conformation. The solution is unusable. To prevent recurrence, verify that your bacteriostatic water is sterile and within its expiration date, inject the water slowly down the vial wall rather than directly onto the powder, and swirl gently without shaking.